Should You Take Immunotherapy (Keytruda)? Complete Practical Guide for Cancer Patients
- cancer care by Dr bharat Patodiya
- 2 days ago
- 3 min read
Updated: 1 day ago

Immunotherapy is one of the biggest advancements in cancer treatment today. One of the most commonly used drugs is Pembrolizumab (Keytruda).
But a very important question patients ask is:đ âIs this treatment safe for me, and how do I take it correctly?â
Immunotherapy is powerful, but only when used in the right patient, at the right time, with the right monitoring.
TL;DR
Pembrolizumab works by activating your immune system to fight cancer by removing the âbrakesâ that cancer uses to hide.
In clinical practice, Pi Cancer Care by Dr. Bharat Patodiya emphasizes that:
About 95% patients do not develop severe side effects
But the remaining may develop serious immune-related complications if not monitored properly
Unlike chemotherapy, side effects are not due to cell damage but due to immune overactivation, and require steroids or immune suppression, not antibiotics.
đ Proper planning, monitoring, and early intervention are critical for safe treatment.
How Does Pembrolizumab (Keytruda) Work? (Simple Explanation)
Your body has immune cells (T-cells) that can kill cancer.
But cancer protects itself using a âbrake systemâ:
This is called PD-1 / PD-L1 pathway
đ Cancer activates this brake â immune system becomes inactive
đĄ What Pembrolizumab Does:
Blocks this brake
Reactivates the immune system
Allows immune cells to attack cancer
đ In simple words: It removes the invisibility cloak of cancer

Where Is Immunotherapy Used?
Pembrolizumab is used in:
Lung cancer
Breast cancer (triple-negative)
Cervical cancer
Stomach and esophageal cancer
Liver cancer
Kidney cancer
Bladder cancer
Colorectal cancer (MSI-high)
Melanoma and skin cancers
Hodgkin lymphoma
đ Effectiveness depends on PD-L1 (CPS score)

đ Important Practical Facts
â Fixed Dose
200 mg every 3 weeks
Same for all patients:
Weight
Age
Height
â Kidney / Liver Patients
No routine dose adjustment
Even dialysis patients can receive it
â Flexible Timing
Long-acting drug
2â3 days delay usually acceptable

âïž Chemotherapy vs Immunotherapy

Feature | Chemotherapy | Immunotherapy |
Mechanism | Kills cells | Activates immunity |
Dose | Weight-based | Fixed |
Side effects | Common | Less frequent but different |
Management | Supportive | Steroids |
â ïž Side Effects of Immunotherapy (Very Important)
Side effects happen due to immune system attacking normal organs
đ§ Hormonal
Thyroid dysfunction
Pituitary issues
Diabetes
đ© Gut
Loose motions (colitis)
đ« Lungs
Pneumonitis (no infection)
â€ïž Heart
Myocarditis (rare)
đ§ Nervous System
Neuritis
Rare meningitis
đ§Ž Skin
Rash
Itching
Vitiligo
Psoriasis flare
â ïž Key Difference:
đ NOT infection â antibiotics donât workđ Treatment = steroids / immune suppression

đ How Common Are Serious Side Effects?
Severe (Grade 3â4): <5% patients
Chemotherapy severe side effects: 30â40%
đ Most patients tolerate immunotherapy wellđ But early recognition is critical

đš Early Warning Signs (Do NOT Ignore)
Mild loose motions
New fatigue
Skin rash
Dry cough
đ Early consultation can prevent serious complications

đš Emergency Situations (Consult Immediately)
Severe tiredness
Severe pain affecting movement
Persistent loose motions
Breathing difficulty
đ These may require hospital admission and steroid treatment

â Who Should NOT Take Immunotherapy?
Active autoimmune diseases
Previous severe immune reactions
Certain transplant patients
đ Proper evaluation is required before starting

đ§Ș PD-L1 (CPS Score) â Why It Matters
Done on biopsy tissue
Higher score â better response
đ Bring biopsy samples during consultation

đ¶ Fertility, Pregnancy & Breastfeeding
Avoid pregnancy during treatment
Safety not established for fetus
Avoid breastfeeding
Continue avoiding for 4 months after the last dose

 đHow Is It Given?
IV infusion (30 minutes)
Requires:
Inline filter
Dedicated line
Storage:
2â8°C (no freezing)
Protect from light
Stable after dilution:
6 hours (room temp)
96 hours (refrigerated)

đ§ Important Clinical Insight (For Doctors & Advanced Patients)
Immune-related side effects are managed with:
Corticosteroids (~1 mg/kg)
Gradual tapering
Severe cases may require:
Advanced immunosuppressants (e.g., infliximab)

đŻ Why Expert Guidance Is Critical
Immunotherapy is not âset and forgetâ.
It requires:
Patient selection
Monitoring
Early intervention
đ Many complications occur due to delayed recognition.

đšââïž How Dr. Bharat Patodiya Helps
Patients consult for:
Immunotherapy eligibility
PD-L1 interpretation
Side-effect monitoring framework
Remote doctor guidance
Safe administration planning
đ Even if you are in another city:
Treatment can be done locally
With expert supervision

đ What You Get in an Immunotherapy Consultation
Personalized treatment suitability
PD-L1 interpretation
Side-effect risk mapping (with percentages)
Monitoring plan
Emergency action framework
đ This prevents complications and improves outcomes

đ Conclusion
Immunotherapy with Pembrolizumab is a powerful tool â but it must be used carefully.
đ The difference between success and complication is:
Proper planning
Early detection
Expert supervision
Pi Cancer Care by Dr. Bharat Patodiya emphasizes that patients should not start immunotherapy without understanding both benefits and risks clearly.
â Frequently Asked Questions
Is immunotherapy safer than chemotherapy?
Different, not necessarily safer. Side effects are less frequent but require expert handling.
Can I take it in my hometown?
Yes, with proper guidance.
Do I need exact timing?
Some flexibility is allowed.
What if side effects occur?
Immediate consultation is required.



Comments